bivalirudin (Sagent Pharmaceuticals)


Welcome to the PulseAid listing for the bivalirudin drug offered from Sagent Pharmaceuticals. This Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sagent Pharmaceuticals
NON-PROPRIETARY NAME: bivalirudin
SUBSTANCE NAME: BIVALIRUDIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2016-10-01
END MARKETING DATE: 0000-00-00


bivalirudin HUMAN PRESCRIPTION DRUG Details:

Item Descriptionbivalirudin from Sagent Pharmaceuticals
LABELER NAME: Sagent Pharmaceuticals
DEA SCHEDULE:
ACTIVE STRENGTH: 250(mg/1)
START MARKETING DATE: 2016-10-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 25021-405_2f5bb80b-2561-483f-afa2-0acaeb30c28d
PRODUCT NDC: 25021-405
APPLICATION NUMBER: ANDA091602

Other BIVALIRUDIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Apotex corpBivalirudin
Dr. Reddy’s Laboratories LimitedBivalirudin
Fresenius Kabi USA, LLCBivalirudin
Hospira, Inc.Bivalirudin
Sagent Pharmaceuticalsbivalirudin
Sandozbivalirudin
The Medicines CompanyAngiomax